Pancreatic Cancer Research

ResearcherShanghai UniversityActive in the last 2 years

Yan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4054-2803; OpenAlex author ID A5100351077. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma. First author DOI 10.14670/hh-18-630↗
  2. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway. Co-author DOI 10.1007/s00210-019-01617-2↗
  3. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity. Last author DOI 10.1007/s13277-016-5311-8↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Qin · 1 shared paper, 2024 · strength 0.31
  2. Zhen Cheng Xu · 1 shared paper, 2024 · strength 0.31
  3. Lei Qin · 1 shared paper, 2019 · strength 0.11
  4. Linxun Liu · 1 shared paper, 2019 · strength 0.11
  5. Genhai Shen · 1 shared paper, 2019 · strength 0.11
  6. Yiliang Bi · 1 shared paper, 2016 · strength 0.08
  7. Wei Shen · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.